| HOME >> BIOLOGY >> TECHNOLOGY |
Prostate cancer biomarkers in semen 292
PSA as biomarker of prostate cancer 292
ProPSA as biomarker of prostate cancer 293
Prostate Health Index 293
Prostasomes in blood as biomarker of prostate cancer 293
PSMA as biomarker of prostate cancer 294
Sarcosine as a metabolic biomarker of prostate cancer 294
Serum HAAH as biomarker of prostate cancer 294
Silenced CDH13 gene as a biomarker of cancer 294
Serum-protein fingerprinting 295
Tests for prostate cancer based on genetic dislocations 295
Concluding remarks on biomarkers of prostate cancer 295
Renal cancer biomarkers 296
Gene expression profile of RCC for biomarkers 296
miRNA biomarkers of renal cancer 296
Use of proteomics for detection of RCC biomarkers 296
Use of RCC biomarkers for prognosis and therapy 297
Thyroid cancer biomarkers 298
Detection of BRAF mutation 298
Gene expression biomarkers of thyroid cancer 298
Multiple endocrine neoplasia type 2B as risk factor for thyroid cancer 298
miRNA biomarkers of thyroid cancer 299
Biochemical biomarkers of thyroid cancer 299
Role of the NCI in molecular diagnosis of cancer 299
The Cancer Genome Anatomy Project 300
Molecular profiling of cancer 300
Cancer Genome Atlas 300
Cancer Genetic Markers of Susceptibility Project 301
Oncology Biomarker Qualification Initiative 301
Role of NCI in cancer biomarker development and validation 302
Projects for cancer biomarker research in Europe 303
COBRED project 303
COLTHERES consortium 304
PREDICT Consortium 304
Future prospects for cancer biomarkers 304
Cancer biomarker research at academic institutions 304
Future prospects and challenges in the discovery of cancer biomarkers 305
7. Biomarkers of Disorders of the Nervous System 307
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |